Embedded Files
研究室メンバーは太字+下線、筆頭著者の場合は * 、責任著者の場合は †
Laboratory members are indicated by bold and underlining ( *: the first author, †: the corresponding author).
Under review
Rising vaccine hesitancy in a future pandemic after COVID-19 and its decision drivers in Japan.
Kawasaki J*, Hamada M*, Machida M, Komorizono R, Kobayashi-Ishihara M, Fujita N, Tabuchi T, Furuse Y†. medRxiv 2026.01.18.26344375; doi: https://doi.org/10.64898/2026.01.18.26344375
Integrative modeling of seasonal influenza evolution via AI-powered antigenic cartography
Ito J*†, Kawakubo S*, Unno H, Strange A, Lytras S, Okumura K, Lilley A, Harvey R, Lewis N, Sato K†. bioRxiv 2025.08.04.668423; doi: https://doi.org/10.1101/2025.08.04.668423
2026
Inferring context-specific site variation with evotuned protein language models.
Lytras S, Strange A, Ito J†, Sato K†. NAR Genom Bioinform. 2026 Feb 9;8(1):lqag018. doi: 10.1093/nargab/lqag018. PMID: 41669667; PMCID: PMC12884077.
2025
A protein language model for exploring viral fitness landscapes.
Ito J*†, Strange A, Liu W, Joas G, Lytras S; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K†. Nat Commun. 2025 May 13;16(1):4236. doi:10.1038/s41467-025-59422-w. PMID: 40360496; PMCID: PMC12075601.
Pathogen genomic surveillance and the AI revolution.
Lytras S, Lamb KD, Ito J, Grove J, Yuan K, Sato K, Hughes J, Robertson DL. J Virol. 2025 Feb 25;99(2):e0160124. doi: 10.1128/jvi.01601-24. Epub 2025 Jan 29. PMID: 39878472; PMCID: PMC11852828.
Hidden challenges in evaluating spillover risk of zoonotic viruses using machine learning models.
Kawasaki J*†, Suzuki T, Hamada M†. Commun Med (Lond). 2025 May 20;5(1):187. doi: 10.1038/s43856-025-00903-w. PMID: 40394176; PMCID: PMC12092720.
Virological characteristics of the SARS-CoV-2 LP.8.1 variant.
Chen L, Kaku Y, Okumura K, Uriu K, Zhu Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Lancet Infect Dis. 2025 Apr;25(4):e193. doi: 10.1016/S1473-3099(25)00079-9. Epub 2025 Feb 10. PMID: 39947218.
Evolution of BA.2.86 to JN.1 reveals that functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2.
Tsujino S, Tsuda M, Nao N, Okumura K, Wang L, Oda Y, Mimura Y, Li J, Hashimoto R, Matsumura Y, Suzuki R, Suzuki S, Yoshimatsu K, Nagao M, Ito J, Takayama K, Sato K, Matsuno K, Tamura T, Tanaka S, Fukuhara T; Genotype to Phenotype Japan (G2P-Japan) Consortium. J Virol. 2025 Oct 23;99(10):e0090825. doi: 10.1128/jvi.00908-25. Epub 2025 Sep 23. PMID: 40985731; PMCID: PMC12548449.
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity.
Tsujino S, Tsuda M, Deguchi S, Ito J, Taha TY, Nasser H, Wang L, Rosecrans J, Suzuki R, Suzuki S, Yoshimatsu K, Ott M, Ikeda T, Sato K, Takayama K, Tanaka S, Tamura T, Fukuhara T; Genotype to Phenotype Japan (G2P-Japan) Consortium. Nat Commun. 2025 Dec 14;17(1):735. doi: 10.1038/s41467-025-67455-4. PMID: 41392175; PMCID: PMC12819382.
Page updated
Google Sites
Report abuse